Evidence map›Paper›PMID 22122586›Full record

ArticleNanomedicine (London, England)2011

Gold nanoprobes for theranostics.

Balaji Panchapakesan, Brittany Book-Newell, Palaniappan Sethu, Madhusudhana Rao, Joseph Irudayaraj

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Nanoparticle-assisted, image-guided laser interstitial thermal therapy for cancer treatment.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022
    Review
  3. Review
  4. Article
  5. Multifunctional FeNanomaterials (Basel, Switzerland) · 2020
    Article
  6. Article
  7. Nanoscale Drug Delivery Systems: From Medicine to Agriculture.Frontiers in bioengineering and biotechnology · 2020
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Balaji PanchapakesanDepartment of Mechanical Engineering, Small Systems Laboratory, University of Louisville, Louisville, KY 40292, USA.
Brittany Book-Newell
Palaniappan Sethu
Madhusudhana Rao
Joseph Irudayaraj

Funding

Chemical Mapping of Chromate Uptake, Localization, and Reduction in Remediating BR01ES017066 · NIEHS · PURDUE UNIVERSITY · PI IRUDAYARAJ, JOSEPH MK · 2009 to 2011
$884k
Label-free, real-time detection of kinase activity in vitro and in single cells uR21CA157395 · NCI · PURDUE UNIVERSITY · PI IRUDAYARAJ, JOSEPH MK · 2011 to 2013
$610k
Nanotube Antibody Arrays for Profiling Circulating Diseased CellsR15CA156322 · NCI · WORCESTER POLYTECHNIC INSTITUTE · PI PANCHAPAKESAN, BALAJI · 2011 to 2011
$463k
NCI NIH HHS R15 CA156322NCI NIH HHS R15CA156322NCI NIH HHS R21 CA157395NIEHS NIH HHS R01 ES017066
6 · The paper itself

Abstract

Gold nanoprobes have become attractive diagnostic and therapeutic agents in medicine and life sciences research owing to their reproducible synthesis with atomic level precision, unique physical and chemical properties, versatility of their morphologies, flexibility in functionalization, ease of targeting, efficiency in drug delivery and opportunities for multimodal therapy. This review highlights some of the recent advances and the potential for gold nanoprobes in theranostics.

Indexed as

Biosensing TechniquesDrug CarriersDrug Delivery SystemsGoldHumansMetal NanoparticlesNanotechnologyPharmaceutical PreparationsPhotosensitizing AgentsSurface PropertiesDrug CarriersGoldPharmaceutical PreparationsPhotosensitizing Agents

Identifiers

PMID22122586
PMCPMC3236610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.